Search Everything in One Place

Explore the web, images, videos, news, and more – all in one place.

Health

Johnson & Johnson's robotic surgery device gets US FDA marketing authorization

China International Import Expo in Shanghai
People gather next to a logo of Johnson & Johnson at the company’s booth at the 8th China International Import Expo (CIIE) in Shanghai, China, November 6, 2025.REUTERS/Maxim Shemetov

July 22 (Reuters) - Johnson & Johnson said on Wednesday the U.S. Food and Drug Administration had granted marketing authorization for its robotic surgery device, clearing the way for the healthcare conglomerate to enter the soft-tissue robotic surgery market. The Ottava robotic surgical system was authorized for use in multiple general surgery procedures in the upper abdomen, including gastric

July 22 (Reuters) - Johnson & Johnson said on Wednesday the U.S. Food and Drug Administration had granted marketing authorization for its robotic surgery device, clearing the way for the healthcare conglomerate to enter the soft-tissue robotic surgery market.

The Ottava robotic surgical system was authorized for use in multiple general surgery procedures in the upper abdomen, including gastric bypass, gastrectomy, gallbladder removal, gastric sleeve surgery, appendectomy and hiatal hernia repair.

J&J said it would begin a U.S. commercial launch with select customers, while working to expand the system into additional indications and regulatory markets.

(Reporting by Puyaan Singh in Bengaluru; Editing by Joyjeet Das)

Related News

More stories you might be interested in.

Top